COMPLEMENT-DEPENDENT SERUM CYTOTOXICITY OF CANCER-PATIENTS STUDIED BY CR-15 RELEASE ASSAY ON HUMAN CANCER LINES

被引：1
|
作者：
PUCHE, JG
CANEVARI, S
FOSSATI, G
DELLAPORTA, G
VEZZONI, P
机构：
[1] IST NAZL TUMORI,DIV EXPTL ONCOL,I-20133 MILAN,ITALY
[2] IST NAZL TUMORI,DIV CLIN ONCOL,I-20133 MILAN,ITALY
来源：
TUMORI | 1977年 / 63卷 / 01期
关键词：
D O I：
10.1177/030089167706300112
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：97 / 107
页数：11
相关论文
共 50 条
  • [1] COMPLEMENT-DEPENDENT CYTOTOXICITY OF SERUM OF PATIENTS WITH MALIGNANT-MELANOMA
    DELLAPORTA, G
    FOSSATI, G
    CANEVARI, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 33 - +
  • [2] USE OF A CR-51-RELEASE TEST FOR DETECTION OF COMPLEMENT-DEPENDENT CYTOTOXICITY OF RAT HEPATOMA-BEARER SERUM
    PRICE, MR
    BRITISH JOURNAL OF CANCER, 1977, 36 (03) : 413 - 413
  • [3] COMPLEMENT-DEPENDENT LYSIS OF ERHLICH ASCITES TUMOR-CELLS BY HUMAN-SERUM (ASCITOLYSIN) IS LOWERED IN CANCER-PATIENTS AND RAISED IN PREGNANT-WOMEN
    GROSS, J
    SIMON, E
    SZWARCBILOTYNSKI, L
    DURST, A
    PFEFFERMAN, R
    POLISHUK, Z
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (01): : 13 - 19
  • [4] Cancer resistance to complement-dependent cytotoxicity (CDC): Problem-oriented research and development
    Gancz, Dana
    Fishelson, Zvi
    MOLECULAR IMMUNOLOGY, 2009, 46 (14) : 2794 - 2800
  • [5] INCREASE OF SERUM COMPLEMENT LEVELS IN CANCER-PATIENTS WITH PROGRESSING TUMORS
    VERHAEGEN, H
    DECOCK, W
    DECREE, J
    VERBRUGGEN, F
    CANCER, 1976, 38 (04) : 1608 - 1613
  • [6] SERUM FACTORS WHICH SUPPRESS NATURAL CYTOTOXICITY IN CANCER-PATIENTS
    HOLMES, E
    SIBBITT, WL
    BANKHURST, AD
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1986, 80 (01): : 39 - 43
  • [7] CR-51 RELEASE CELLULAR LYMPHOCYTE CYTOTOXICITY AS A POSSIBLE MEASURE OF IMMUNOLOGICAL COMPETENCE OF CANCER-PATIENTS
    MCCOY, J
    HERBERMA.R
    PERLIN, E
    LEVINE, P
    ALFORD, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 107 - &
  • [8] Supramolecular assembly of antibody-rhamnose complex to enhance the complement-dependent cytotoxicity for cancer immunotherapy
    Hong, Haofei
    Zhou, Kun
    Lin, Han
    Wu, Zhimeng
    JOURNAL OF CARBOHYDRATE CHEMISTRY, 2024,
  • [9] Epithelial-mesenchymal transition confers resistance to complement-dependent cytotoxicity in lung cancer cells
    Goswami, Moloy T.
    Reka, Ajaya K.
    Kurapati, Himabindu
    Kaza, Viritha
    Keshamouni, Venkateshwar G.
    CANCER RESEARCH, 2012, 72
  • [10] SERUM COMPLEMENT LEVELS IN CANCER-PATIENTS BEFORE AND AFTER SURGICAL TREATMENT
    SCHENA, FP
    PASTORE, A
    PERTOSA, G
    PISCITELLI, M
    PATHOLOGIE BIOLOGIE, 1977, 25 (06): : 401 - 402
12345